P3 HEALTH PARTNERS INC. - CLASS A COMMON STOCK

P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results; Increases 2022 Revenue Outlook

20 Oct 2022 16:14:55 By Nasdaq GlobeNewswire

P3 Health Partners Announces Chief Financial Officer Transition Appoints Erin Darakjian as Interim CFO

20 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

P3 Health Partners to Present 1H 2022 Financial Results

20 Oct 2022 08:30:00 By Nasdaq GlobeNewswire

P3 Health Partners Fireside Chat Hosted by LifeSci Advisors, LLC

26 Aug 2022 10:06:01 By Nasdaq GlobeNewswire

P3 Health Partners CEO Dr. Sherif Abdou Featured on Benchtop Bios Podcast

22 Aug 2022 16:05:00 By Nasdaq GlobeNewswire

P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Report

19 Aug 2022 16:30:00 By Nasdaq GlobeNewswire

Oregon State Athletics, P3 Health Partners Oregon Announce Multi-Year Relationship

11 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

P3 Health Partners Announces Inclusion in the Russell 3000® Index

27 Jun 2022 08:30:00 By Nasdaq GlobeNewswire

P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Reports

24 May 2022 08:30:00 By Nasdaq GlobeNewswire

P3 Health Partners to Present Fourth Quarter and Full Year 2021 Financial Results

14 Apr 2022 08:00:00 By Nasdaq GlobeNewswire

P3 Health Partners Announces Select Preliminary Fourth Quarter and Full Year 2021 Results, and Introduces 2022 Outlook

09 Mar 2022 08:00:00 By Nasdaq GlobeNewswire

P3 Health Partners to Participate at Upcoming Investor Conferences

07 Mar 2022 08:30:01 By Nasdaq GlobeNewswire

P3 Health Partners Expands to California, Closes Acquisition of Medcore HP and Omni IPA Medical Group, Inc.

04 Jan 2022 08:00:02 By Nasdaq GlobeNewswire